Drug interactions between Crestor and Norvasc
| Results for the following 2 drugs: |
|---|
| Crestor (rosuvastatin) |
| Norvasc (amlodipine) |
Interactions between your drugs
There were no interactions found in our database between Crestor and Norvasc - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Crestor
A total of 274 drugs are known to interact with Crestor.
- Crestor is in the drug class statins.
- Crestor is used to treat the following conditions:
- Atherosclerosis
- High Cholesterol
- High Cholesterol, Familial Heterozygous
- High Cholesterol, Familial Homozygous
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Hypertriglyceridemia
- Prevention of Cardiovascular Disease
Norvasc
A total of 707 drugs are known to interact with Norvasc.
- Norvasc is a member of the drug class calcium channel blocking agents.
- Norvasc is used to treat the following conditions:
Drug and food interactions
amLODIPine food
Applies to: Norvasc (amlodipine)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
